T. Rowe Price Associates’s MGP Ingredients MGPI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-8,383
Closed -$204K 3173
2025
Q4
$204K Buy
+8,383
New +$204K ﹤0.01% 2800
2025
Q3
Sell
-6,782
Closed -$204K 3089
2025
Q2
$204K Buy
+6,782
New +$202K ﹤0.01% 2705
2025
Q1
Sell
-5,662
Closed -$223K 3061
2024
Q4
$223K Buy
5,662
+1,015
+22% +$55.2K ﹤0.01% 2635
2024
Q3
$387K Buy
4,647
+32
+0.7% +$2.65K ﹤0.01% 2359
2024
Q2
$344K Buy
4,615
+82
+2% +$6.4K ﹤0.01% 2357
2024
Q1
$391K Buy
4,533
+578
+15% +$50.1K ﹤0.01% 2308
2023
Q4
$390K Buy
3,955
+331
+9% +$31.8K ﹤0.01% 2280
2023
Q3
$383K Buy
3,624
+412
+13% +$46.7K ﹤0.01% 2239
2023
Q2
$342K Buy
3,212
+509
+19% +$50.9K ﹤0.01% 2308
2023
Q1
$262K Buy
2,703
+255
+10% +$24.9K ﹤0.01% 2411
2022
Q4
$260K Buy
2,448
+188
+8% +$21K ﹤0.01% 2431
2022
Q3
$240K Buy
+2,260
New +$243K ﹤0.01% 2475

Other funds holding MGPI

T. Rowe Price Associates's MGPI Position: Q1 2026 in Review

T. Rowe Price Associates sold out of MGP Ingredients (MGPI) in Q1 2026, closing a stake of 8,383 shares — an estimated $204K sold.

T. Rowe Price Associates first reported a position in MGPI in Q3 2022 and held it in 12 quarters. The position peaked at $391K in Q1 2024. 146 funds tracked by Wall St. Rank hold MGPI as of Q1 2026.

  • T. Rowe Price Associates reported no remaining MGP Ingredients position as of Q1 2026 after selling out during the quarter.
  • T. Rowe Price Associates sold 8,383 MGP Ingredients shares in Q1 2026, an estimated $204K.
  • T. Rowe Price Associates first reported a position in MGP Ingredients in Q3 2022 and held it in 12 quarters.
  • T. Rowe Price Associates's MGP Ingredients position peaked at $391K in Q1 2024.
  • 146 funds tracked by Wall St. Rank held MGP Ingredients as of Q1 2026.

Based on T. Rowe Price Associates's 13F filing for Q1 2026, filed 15 May 2026.